Clarivate(CLVT) - 2025 Q4 - Annual Report

Revenue Performance - Revenues for 2025 were $2,455.2 million, a decrease of $101.5 million or 4% compared to 2024[174]. - Total revenues for the year ended December 31, 2025, were $2,455.2 million, a decrease of 3.96% from $2,556.7 million in 2024[244]. - Subscription revenues decreased by 1.3% to $1,605.5 million, while transactional revenues fell by 16.9% to $415.5 million[176]. - The A&G segment revenues decreased by 4.6% to $1,266.0 million, primarily due to product group wind-downs and the ScholarOne divestiture[179]. - Revenue from the Americas was $1,303.0 million in 2025, down from $1,381.4 million in 2024, a decrease of 5.6%[303]. Profitability and Loss - Net income for 2025 was a loss of $201.1 million, compared to a loss of $636.7 million in 2024[174]. - The net loss for 2025 was $201.1 million, compared to a net loss of $636.7 million in 2024, indicating an improvement of 68.4%[246]. - The company reported a comprehensive loss of $127.9 million for 2025, compared to a comprehensive loss of $667.7 million in 2024[246]. - The company recorded a substantial goodwill impairment charge of $525.7 million in 2024, reflecting a 97% decrease from the previous year[174]. Cash Flow and Liquidity - Free cash flow increased to $365.3 million in 2025, up 2% from $357.5 million in 2024, primarily due to reduced capital expenditures[206]. - Cash on hand as of December 31, 2025, was $329.2 million, with an additional $768.5 million available under the revolving credit facility[200]. - Cash flows from operating activities provided $628.5 million in 2025, slightly down from $646.6 million in 2024[252]. - The company expects to fund future capital expenditures primarily through cash flows from operations, with adequate resources to meet liquidity needs and service debt[216]. Expenses and Cost Management - Total operating expenses for 2025 were $2,383.7 million, down from $2,832.3 million in 2024[174]. - Operating expenses totaled $2,383.7 million in 2025, down from $2,832.3 million in 2024, reflecting a reduction of 15.83%[244]. - Principal payments on debt rose significantly to $600.0 million in 2025 from $198.1 million in 2024[252]. - Restructuring and other impairments amounted to $18.6 million in 2025, significantly lower than $540.3 million in 2024[252]. Asset and Liability Management - Total assets decreased to $11,069.4 million in 2025 from $11,490.2 million in 2024, a decline of 3.67%[242]. - Current liabilities increased to $1,568.8 million in 2025 from $1,433.5 million in 2024, an increase of 9.4%[242]. - The company’s long-term debt as of December 31, 2025, was $4,321.5 million, a decrease from $4,518.7 million in 2024[245]. - The company’s accumulated deficit increased to $7,514.6 million in 2025 from $7,313.5 million in 2024[245]. Goodwill and Impairment - Goodwill impairment assessments showed a total impairment of $847.7 million in 2023, primarily due to worsening macroeconomic conditions[160]. - In 2025, the A&G reporting unit's fair value was approximately 12% in excess of its carrying value, indicating no impairment charge was required[162]. - No impairments of indefinite-lived intangible assets were identified in 2025, 2024, or 2023[167]. - The company recorded a goodwill impairment charge of $465.7 million in 2024 primarily due to adverse market conditions[313]. Future Outlook and Plans - The company expects to incur approximately $25 million in additional costs related to the Value Creation Plan in 2026[193]. - Capital expenditures for 2026 are estimated at approximately $250 million, primarily for product and content development[212]. - The company has a share repurchase program authorized for up to $500 million, with $275.5 million remaining as of December 31, 2025[211]. Financial Instruments and Risk Management - The company has outstanding interest rate swaps with an aggregate notional value of $1,756.9 million as of December 31, 2025, aimed at managing interest rate risk[326]. - The company entered into three cross-currency swaps in June and December 2025 with a combined notional value of €448.0 million, maturing in January 2031, to mitigate foreign currency exposure and reduce interest expense[328]. - The notional amount of outstanding foreign currency forward contracts as of December 31, 2025, was $162.1 million, an increase from $91.1 million as of December 31, 2024[332].

Clarivate(CLVT) - 2025 Q4 - Annual Report - Reportify